Skip to main content

Table 4 Baseline characteristics of chronic start dialysis patients stratified by access

From: The impact of an “acute dialysis start” on the mortality attributed to the use of central venous catheters: a retrospective cohort study

Variable

CVC access (n = 182)

PD or fistula access (n = 167)

P

Age at dialysis start, years, (mean ± SD)

62 ± 16.0

62 ± 16

0.95

Male gender, n (%)

96 (53)

106 (63)

0.05

Caucasian race, n (%)

166 (91)

157 (94)

0.42

Dialysis Access, n (%)

CVC

56 (98)

182 (52)

<0.001

AVF

1 (2)

95 (27)

<0.001

PD catheter

0

72 (21)

<0.001

Cause of ESRD, n (%)

Diabetes

64 (35)

46 (28)

0.14

Polycystic kidney disease

9 (5)

21 (13)

0.01

Glomerulonephritis

23 (13)

22 (13)

1.00

Referral time before dialysis start, days, (median, IQR)

734, 196 to 1966

1623, 687 to 3115

<0.001

Referral < 3 months, n (%)

32 (18)

2 (1)

<0.001

Comorbidity

CCI (median, IQR)

5, 3 to 7

3, 2 to 6

<0.001

Diabetes, n (%)

91 (50)

63 (38)

0.02

Coronary artery disease, n (%)

62 (34)

38 (23)

0.02

Congestive heart failure, n (%)

44 (24)

33 (20)

0.37

Peripheral vascular disease n (%)

54 (30)

24 (14)

0.001

Malignancya, n (%)

23 (13)

11 (7)

0.07

Laboratory Values

Hemoglobin, g/L, (mean ± SD)

96 ± 17

105 ± 17

<0.001

Albumin, g/L, (median, IQR)

31, 25 to 34

34, 31 to 38

<0.001

Phosphate, mmol/L, (median, IQR)

1.8, 1.5 to 2.3

1.8, 1.5 to 2.2

0.19

Imputed phosphateb

1.9, 1.6 to 2.3

1.8, 1.5 to 2.1

0.13

eGFR, ml/min/1.73 m2, (median, IQR)

7.2, 5.8 to 9.7

8.1, 6.2 to 10.9

0.01

Imputed eGFRc

7.3, 5.8 to 9.6

8.1, 6.2 to 10.9

0.01

  1. a: Including hematologic or non-hematologic, excluding non-melanoma skin CA.
  2. b: 21 missing values imputed.
  3. c: 3 missing values imputed.